The Food and Drug Administration (FDA) has expanded its approval of a ketamine-derived nasal spray, Spravato (esketamine), as a standalone therapy for adults with treatment-resistant depression.

Languages: English. North Korean troops have pulled back from at least one section of the frontline in the Kursk region of Russia, according to members of Ukraine's military. Sky News on Monday ...

The FDA’s latest approval of the nasal spray Spravato (esketamine) CIII marks a major shift in how major depressive disorder is managed, allowing people who have tried at least two oral ...

Russia's losses in the war According to the General Staff, since the beginning of the full-scale war against Ukraine, Russia has lost over 825,000 military personnel. Notably, in the past day ...

The nasal spray Spravato, which is made from the drug esketamine, had been approved in 2019 for patients who failed to respond to at least two oral antidepressants. However, it had to be used in ...

Johnson & Johnson has announced the FDA’s approval of a first-of-its-kind, esketamine nasal spray called Spravato for the standalone treatment of major depressive disorder (MDD), PTSD ...

Jan. 21 (UPI) --The Food and Drug Administration has approved the first-ever stand-alone nasal spray to treat drug-resistant depression. Johnson & Johnson's Spravato has been approved to treat a ...

NEW YORK (PIX11) – A nose spray has been approved by the U.S. Food and Drug Administration to help treat depression, Johnson & Johnson announced on Tuesday. Spravato is a first-of-its-kind ...

they are likely to miss some of the important instructions to be announced in the examination rooms/ halls. The NTA will not be responsible for any delay of the candidate to reach the examination ...

The events of Jan. 6 were seen at the time as “universally terrible,” former Fox News anchor Megyn Kelly, host of The Megyn Kelly Show, tells FRONTLINE in the new documentary Trump’s Comeback.